NCT02736279View on ClinicalTrials.gov

Impact of Tecfidera on Gut Microbiota

UnknownOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

June 30, 2020

Study Completion Date

December 31, 2020

Conditions
Multiple Sclerosis
Interventions
DRUG

Dimethyl fumarate

Observation of impact of dimethyl fumarate treatment initiation on mood and gut microbiome over the first 6 months of therapy

Trial Locations (1)

98034

RECRUITING

EvergreenHealth MS Center, Kirkland

Sponsors

Collaborators (1)

Biogen
All Listed Sponsors
collaborator

Biogen

INDUSTRY

lead

Virginia Simnad

OTHER

NCT02736279 - Impact of Tecfidera on Gut Microbiota | Biotech Hunter | Biotech Hunter